Sernova Corp. (SVA.TO)
CAD 0.23
(0.0%)
CAD 0.23
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -8.58 Million CAD | -145.3% |
| 2022 | -3.5 Million CAD | 87.26% |
| 2021 | -27.48 Million CAD | -746.4% |
| 2020 | -3.24 Million CAD | -80.67% |
| 2019 | -1.79 Million CAD | -3.32% |
| 2018 | -1.73 Million CAD | 33.8% |
| 2017 | -2.62 Million CAD | 49.47% |
| 2016 | -5.19 Million CAD | -2353.29% |
| 2015 | -211.93 Thousand CAD | 54.3% |
| 2014 | -463.8 Thousand CAD | -69.52% |
| 2013 | -273.6 Thousand CAD | -7.06% |
| 2012 | -255.55 Thousand CAD | 17.56% |
| 2011 | -309.99 Thousand CAD | 57.83% |
| 2010 | -735.14 Thousand CAD | -85.19% |
| 2009 | -396.96 Thousand CAD | 13.96% |
| 2008 | -461.34 Thousand CAD | 74.37% |
| 2007 | -1.8 Million CAD | 37.38% |
| 2006 | -2.87 Million CAD | -902.74% |
| 2005 | -286.68 Thousand CAD | -54.51% |
| 2004 | -185.54 Thousand CAD | -43.84% |
| 2003 | -128.99 Thousand CAD | 62.27% |
| 2002 | -341.93 Thousand CAD | 78.38% |
| 2001 | -1.58 Million CAD | -437.09% |
| 2000 | -294.41 Thousand CAD | 26.63% |
| 1999 | -401.26 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -5.87 Million CAD | 31.57% |
| 2024 Q2 | -2.82 Million CAD | 51.93% |
| 2024 Q3 | -4.42 Million CAD | -56.76% |
| 2023 FY | -8.58 Million CAD | -145.3% |
| 2023 Q4 | -8.58 Million CAD | 51.23% |
| 2023 Q1 | -22.25 Million CAD | -535.75% |
| 2023 Q3 | -17.6 Million CAD | -41.14% |
| 2023 Q2 | -12.47 Million CAD | 43.95% |
| 2022 FY | -3.5 Million CAD | 87.26% |
| 2022 Q2 | -23.9 Million CAD | 10.86% |
| 2022 Q3 | -2.71 Million CAD | 88.66% |
| 2022 Q1 | -26.81 Million CAD | 2.43% |
| 2022 Q4 | -3.5 Million CAD | -29.13% |
| 2021 Q1 | -9.13 Million CAD | -181.26% |
| 2021 Q3 | -29.88 Million CAD | 3.74% |
| 2021 FY | -27.48 Million CAD | -746.4% |
| 2021 Q4 | -27.48 Million CAD | 8.05% |
| 2021 Q2 | -31.04 Million CAD | -239.99% |
| 2020 Q1 | -872.19 Thousand CAD | 51.47% |
| 2020 Q3 | -88.38 Thousand CAD | 77.31% |
| 2020 Q4 | -3.24 Million CAD | -3573.68% |
| 2020 FY | -3.24 Million CAD | -80.67% |
| 2020 Q2 | -389.56 Thousand CAD | 55.34% |
| 2019 Q1 | -1.2 Million CAD | 30.69% |
| 2019 Q4 | -1.79 Million CAD | -296.19% |
| 2019 Q3 | -453.6 Thousand CAD | 25.76% |
| 2019 FY | -1.79 Million CAD | -3.32% |
| 2019 Q2 | -611.02 Thousand CAD | 49.32% |
| 2018 Q3 | -2.19 Million CAD | -59.17% |
| 2018 Q4 | -1.73 Million CAD | 20.91% |
| 2018 Q1 | -2.28 Million CAD | 13.17% |
| 2018 Q2 | -1.38 Million CAD | 39.44% |
| 2018 FY | -1.73 Million CAD | 33.8% |
| 2017 Q4 | -2.62 Million CAD | 29.66% |
| 2017 FY | -2.62 Million CAD | 49.47% |
| 2017 Q3 | -3.73 Million CAD | 29.7% |
| 2017 Q2 | -5.31 Million CAD | -0.16% |
| 2017 Q1 | -5.3 Million CAD | -2.04% |
| 2016 FY | -5.19 Million CAD | -2353.29% |
| 2016 Q4 | -5.19 Million CAD | -4.29% |
| 2016 Q3 | -4.98 Million CAD | -72.11% |
| 2016 Q2 | -2.89 Million CAD | -163.2% |
| 2016 Q1 | -1.1 Million CAD | -419.31% |
| 2015 Q4 | -211.93 Thousand CAD | -9.3% |
| 2015 FY | -211.93 Thousand CAD | 54.3% |
| 2015 Q1 | -401.27 Thousand CAD | 13.48% |
| 2015 Q3 | -193.91 Thousand CAD | -30.38% |
| 2015 Q2 | -148.72 Thousand CAD | 62.94% |
| 2014 Q2 | -166.4 Thousand CAD | 24.77% |
| 2014 FY | -463.8 Thousand CAD | -69.52% |
| 2014 Q3 | -433.71 Thousand CAD | -160.63% |
| 2014 Q4 | -463.8 Thousand CAD | -6.94% |
| 2014 Q1 | -221.2 Thousand CAD | 19.15% |
| 2013 Q1 | -524.87 Thousand CAD | -105.39% |
| 2013 FY | -273.6 Thousand CAD | -7.06% |
| 2013 Q4 | -273.6 Thousand CAD | -17.14% |
| 2013 Q3 | -233.56 Thousand CAD | -156.71% |
| 2013 Q2 | -90.98 Thousand CAD | 82.67% |
| 2012 Q3 | -163.51 Thousand CAD | 50.27% |
| 2012 Q1 | -114.92 Thousand CAD | 62.93% |
| 2012 FY | -255.55 Thousand CAD | 17.56% |
| 2012 Q2 | -328.83 Thousand CAD | -186.14% |
| 2012 Q4 | -255.55 Thousand CAD | -56.29% |
| 2011 Q3 | -1.45 Million CAD | -78.37% |
| 2011 FY | -309.99 Thousand CAD | 57.83% |
| 2011 Q1 | -1.06 Million CAD | -45.47% |
| 2011 Q2 | -816.02 Thousand CAD | 23.7% |
| 2011 Q4 | -309.99 Thousand CAD | 78.7% |
| 2010 Q1 | -196.86 Thousand CAD | 50.41% |
| 2010 FY | -735.14 Thousand CAD | -85.19% |
| 2010 Q4 | -735.14 Thousand CAD | -59.19% |
| 2010 Q3 | -461.8 Thousand CAD | -23.77% |
| 2010 Q2 | -373.12 Thousand CAD | -89.53% |
| 2009 FY | -396.96 Thousand CAD | 13.96% |
| 2009 Q2 | -150.3 Thousand CAD | 53.9% |
| 2009 Q3 | -373.22 Thousand CAD | -148.31% |
| 2009 Q4 | -396.96 Thousand CAD | -6.36% |
| 2009 Q1 | -326.05 Thousand CAD | 29.33% |
| 2008 Q1 | -1.39 Million CAD | 22.67% |
| 2008 Q3 | -712.69 Thousand CAD | 30.02% |
| 2008 Q2 | -1.01 Million CAD | 26.84% |
| 2008 FY | -461.34 Thousand CAD | 74.37% |
| 2008 Q4 | -461.34 Thousand CAD | 35.27% |
| 2007 Q4 | -1.8 Million CAD | 10.71% |
| 2007 Q3 | -2.01 Million CAD | -9.34% |
| 2007 Q2 | -1.84 Million CAD | 24.82% |
| 2007 Q1 | -2.45 Million CAD | 14.68% |
| 2007 FY | -1.8 Million CAD | 37.38% |
| 2006 FY | -2.87 Million CAD | -902.74% |
| 2006 Q4 | -2.87 Million CAD | 9.51% |
| 2006 Q3 | -3.17 Million CAD | -646.93% |
| 2006 Q2 | -425.34 Thousand CAD | -82.84% |
| 2006 Q1 | -232.63 Thousand CAD | 18.86% |
| 2005 Q2 | -29.67 Thousand CAD | 84.45% |
| 2005 Q4 | -286.68 Thousand CAD | 33.91% |
| 2005 FY | -286.68 Thousand CAD | -54.51% |
| 2005 Q3 | -433.77 Thousand CAD | -1361.83% |
| 2005 Q1 | -190.84 Thousand CAD | -2.86% |
| 2004 Q4 | -185.54 Thousand CAD | -1040.65% |
| 2004 Q1 | -65.05 Thousand CAD | 49.57% |
| 2004 FY | -185.54 Thousand CAD | -43.84% |
| 2004 Q2 | 186.67 Thousand CAD | 386.93% |
| 2004 Q3 | 19.72 Thousand CAD | -89.43% |
| 2003 Q3 | -282.18 Thousand CAD | 6.25% |
| 2003 Q4 | -128.99 Thousand CAD | 54.29% |
| 2003 Q2 | -300.99 Thousand CAD | 45.37% |
| 2003 Q1 | -550.95 Thousand CAD | -61.13% |
| 2003 FY | -128.99 Thousand CAD | 62.27% |
| 2002 Q1 | -1.05 Million CAD | 0.0% |
| 2002 FY | -341.93 Thousand CAD | 78.38% |
| 2002 Q2 | -495.2 Thousand CAD | 52.86% |
| 2002 Q3 | -195.15 Thousand CAD | 60.59% |
| 2002 Q4 | -341.93 Thousand CAD | -75.21% |
| 2001 FY | -1.58 Million CAD | -437.09% |
| 2000 FY | -294.41 Thousand CAD | 26.63% |
| 1999 FY | -401.26 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Appili Therapeutics Inc. | 8.09 Million CAD | 206.123% |
| Eupraxia Pharmaceuticals Inc. | -11.72 Million CAD | 26.756% |
| Helix BioPharma Corp. | -1.08 Million CAD | -694.238% |
| Microbix Biosystems Inc. | -4.96 Million CAD | -73.058% |
| Medicenna Therapeutics Corp. | -16.98 Million CAD | 49.442% |
| Satellos Bioscience Inc. | -22.06 Million CAD | 61.093% |
| Oncolytics Biotech Inc. | -31.11 Million CAD | 72.403% |